Azra AI is touting a milestone in the use of its artificial intelligence (AI) technology for identifying cancer diagnoses in real-time and in turn, improving patient care.
The company said its technology is being used by over 200 hospitals and that it has shown promise in decreasing the amount of time from diagnosis to treatment by seven days across all cancer types.
Azra also said that its acquisition of the company Digital Reasoning, with funding from Sopris Capital and FCA Venture Partners, will allow the company to expand and accelerate its software across oncology and other healthcare service lines.
